The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation

Marília I Figueira1, Henrique J Cardoso1, Sara Correia1

  • 1CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.

Cancer Letters
|July 29, 2017
PubMed

Insights

The stem cell factor (SCF)/c-KIT system regulates reproductive functions and is implicated in reproductive cancers. Hormonal imbalances can disrupt SCF/c-KIT, potentially driving cancer development and offering new therapeutic targets.

Area of Science:

  • Reproductive Biology
  • Molecular Oncology
  • Endocrinology

Background:

  • The stem cell factor (SCF) and its receptor c-KIT are crucial for reproductive tract functions, including cell survival, death, differentiation, and migration.
  • Aberrant SCF/c-KIT signaling, due to mutations or altered expression, is linked to reproductive tissue carcinogenesis.
  • Hormones, key regulators of reproductive function and hormone-dependent cancers, also influence SCF/c-KIT levels.

Purpose of the Study:

  • To review the expression of SCF and c-KIT in reproductive cancers.
  • To discuss the role of hormonal regulation in the SCF/c-KIT system's involvement in cancer development.
  • To highlight the potential of targeting the SCF/c-KIT pathway in reproductive cancer therapy.

Main Methods:

  • Literature review of studies on SCF and c-KIT expression in reproductive tissues and cancers.
  • Analysis of the interplay between hormonal regulation and SCF/c-KIT signaling.
  • Discussion of the implications for cancer development and therapeutic strategies.

Main Results:

  • SCF and c-KIT are expressed in the male and female reproductive tracts, regulating fundamental biological processes.
  • Altered SCF/c-KIT expression or activity, influenced by hormonal dysregulation, is implicated in the initiation and progression of reproductive cancers.
  • The SCF/c-KIT system's role in carcinogenesis is further complicated by its interaction with hormonal signaling pathways.

Conclusions:

  • Understanding the intricate relationship between hormonal imbalance and SCF/c-KIT expression is vital for comprehending reproductive cancer development.
  • Targeting the SCF/c-KIT pathway, modulated by hormones, presents a promising avenue for novel therapeutic interventions in reproductive cancers.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K